BEUDAMED
    FDA PMA FDA Class 3 Approved 🇺🇸 United States

    System, Endovascular Graft, Aortic Aneurysm Treatment

    PMA: P020004 · Supplement: S004 · Decision Oct 15, 2003
    View on FDA
    Classifications
    1
    FEI Numbers
    34
    Registration Numbers
    34

    Basic Information

    Device Name
    System, Endovascular Graft, Aortic Aneurysm Treatment
    Trade Name
    GORE EXCLUDER BIFURCATED ENDOPROSTHESIS
    PMA Number
    P020004
    Supplement Number
    S004
    Device Class
    FDA Class 3
    Product Code
    MIH
    Generic Name
    SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
    Medical Specialty
    Unknown
    Advisory Committee
    Cardiovascular
    Decision
    Approved
    Decision Code
    APPR
    Decision Date
    October 15, 2003
    Date Received
    May 27, 2003
    Supplement Type
    Normal 180 Day Track
    Supplement Reason
    Change Design/Components/Specifications/Material
    Expedited Review
    N

    Advisory Committee Statement

    APPROVAL FOR THE ADDITION OF LARGER SIZE CONTRALATERAL LEG COMPONENTS FOR THE EXCLUDER BIFURCATED ENDOPROSTHESIS (EBE) AND FOR THE ADDITION OF THE W.L. GORE & ASSOCIATES WOODY SPRINGS FACILITY LOCATED IN FLAGSTAFF, ARIZONA, WHICH WILL BE USED TO MANUFACTURE THE LARGER SIZED CONTRALATERAL LEG COMPONENTS.

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    MIH System, Endovascular Graft, Aortic Aneurysm Treatment